CG MedTechLtd Past Earnings Performance

Past criteria checks 0/6

CG MedTechLtd has been growing earnings at an average annual rate of 16.2%, while the Medical Equipment industry saw earnings growing at 19.3% annually. Revenues have been growing at an average rate of 3.3% per year.

Key information

16.2%

Earnings growth rate

18.3%

EPS growth rate

Medical Equipment Industry Growth	22.7%
Revenue growth rate	3.3%
Return on equity	-2.9%
Net Margin	-5.1%
Last Earnings Update	30 Sep 2024

Recent past performance updates

No updates

Recent updates

Does U&I (KOSDAQ:056090) Have A Healthy Balance Sheet?

May 04

We Think U&I (KOSDAQ:056090) Has A Fair Chunk Of Debt

Jan 11

Revenue & Expenses Breakdown

How CG MedTechLtd makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

KOSDAQ:A056090 Revenue, expenses and earnings (KRW Millions)
Date	Revenue	Earnings	G+A Expenses	R&D Expenses
30 Sep 24	35,387	-1,790	7,783	4,462
30 Jun 24	35,890	1,976	9,000	4,462
31 Mar 24	35,276	1,398	9,994	4,462
31 Dec 23	34,969	1,629	10,034	4,462
30 Sep 23	33,362	101,946	28,937	943
30 Jun 23	35,607	-19,518	27,182	2,168
31 Mar 23	40,546	-18,606	25,040	3,351
31 Dec 22	41,169	-18,540	23,366	4,471
30 Sep 22	43,001	-122,338	12,053	4,608
30 Jun 22	40,778	-4,506	11,042	4,669
31 Mar 22	38,327	-5,473	10,801	4,995
31 Dec 21	38,055	-4,970	10,417	4,893
30 Sep 21	34,261	-6,716	10,815	4,927
30 Jun 21	32,083	-8,593	10,954	4,591
31 Mar 21	29,470	-12,230	11,280	4,387
31 Dec 20	27,775	-12,283	11,475	4,462
30 Sep 20	31,497	-8,062	11,099	4,735
30 Jun 20	32,334	-6,239	10,569	4,704
31 Mar 20	33,156	-2,150	9,761	4,459
31 Dec 19	34,814	-1,890	9,442	4,329
30 Sep 19	31,831	-11,372	9,498	4,080
30 Jun 19	31,966	-13,810	9,700	4,184
31 Mar 19	32,092	-14,776	9,835	3,968
31 Dec 18	31,686	-14,719	9,508	3,877
30 Sep 18	27,160	-6,830	7,982	3,719
30 Jun 18	23,172	-5,697	7,051	3,622
31 Mar 18	18,209	-5,583	6,340	3,535
31 Dec 17	13,294	-6,545	5,421	3,253
30 Sep 17	12,400	-4,988	6,171	3,637
30 Jun 17	12,880	-3,263	6,329	3,332
31 Mar 17	11,832	-3,224	6,026	3,026
31 Dec 16	11,688	-2,076	5,721	3,117
30 Sep 16	13,393	-680	5,889	3,213
30 Jun 16	11,967	-1,484	6,036	3,224
31 Dec 15	14,596	-811	6,691	2,814

Quality Earnings: A056090 is currently unprofitable.

Growing Profit Margin: A056090 is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: A056090 is unprofitable, but has reduced losses over the past 5 years at a rate of 16.2% per year.

Accelerating Growth: Unable to compare A056090's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A056090 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-16.5%).

Return on Equity

High ROE: A056090 has a negative Return on Equity (-2.94%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/04 00:07
End of Day Share Price	2025/01/03 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

CG MedTech Co.,Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
In Pil Kim	Cape Investment & Securities Co., Ltd.
Ji-Hyun Lee	Kiwoom Securities Co., Ltd.